Financial reports - Theratechnologies, TSX TH, Tesamorelin, Lipohypertrophy, Lipodystrophy treatment

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

2009 Annual Report

2009 Annual Report

2009 Annual Report - COMPLETE (PDF: 2.2 Mb)
2009 Highlights and Corporate Overview (PDF: 1.7 Mb)
Chairman’s Letter (PDF: 72 Kb)
Message from the President and CEO (PDF: 744 Kb)
Management’s Discussion and Analysis (PDF: 288 Kb)
Consolidated Financial Statements (PDF: 316 Kb)
Consolidated Financial Statements (MS Excel: 56 Kb)

Terms of use